Pharmacology, Toxicology and Pharmaceutical Science
Heart Failure
100%
Acute Heart Failure
25%
Iron Deficiency
20%
Erythropoietin
16%
Biological Marker
15%
Anemia
13%
Placebo
13%
Heart Failure with Reduced Ejection Fraction
13%
Heart Infarction
12%
Acute Heart Infarction
12%
Disease
11%
Cardiomyopathy
8%
Ferric Carboxymaltose
8%
Heart Failure with Preserved Ejection Fraction
8%
Congestive Heart Failure
7%
Angiotensin
7%
Prevalence
6%
Pathophysiology
6%
All Cause Mortality
6%
Malignant Neoplasm
6%
Hyperkalemia
6%
Dipeptidyl Carboxypeptidase Inhibitor
6%
Chronic Kidney Failure
5%
Valsartan/Sacubitril
5%
Medicine and Dentistry
Heart Failure
76%
Ejection Fraction
15%
Acute Decompensated Heart Failure
14%
Heart Failure with Preserved Ejection Fraction
13%
Iron Deficiency
12%
Cardiovascular System
12%
Peripartum Cardiomyopathy
11%
Disease
10%
Heart Failure with Reduced Ejection Fraction
10%
Biological Marker
10%
Anemia
9%
Cardiology
9%
Malignant Neoplasm
8%
Heart Left Ventricle Ejection Fraction
8%
Heart Function
8%
Congestive Heart Failure
7%
Placebo
7%
Oncology
6%
Cardiovascular Disease
6%
Cardiomyopathy
6%
Pathophysiology
6%
Exercise
6%
Atrial Fibrillation
5%
Erythropoietin
5%
Amino Terminal Sequence
5%
Transthyretin
5%
Semaglutide
5%
Keyphrases
Heart Failure
36%
Acute Heart Failure
22%
Patients with Heart Failure
17%
Heart Failure with Preserved Ejection Fraction (HFpEF)
16%
Iron Deficiency
15%
Heart Failure Patients
9%
Heart Failure Hospitalization
9%
Peripartum Cardiomyopathy
9%
Confidence Interval
8%
Ferric Carboxymaltose
7%
Placebo
7%
Acute Myocardial Infarction
7%
Anemia
7%
Chronic Heart Failure
6%
Comorbidity
6%
Hazard Ratio
6%
All-cause Mortality
6%
Preserved Ejection Fraction
6%
Myocardial Infarction
6%
Left Ventricular Ejection Fraction
6%
Hyperkalemia
5%
Cardiomyopathy
5%
Clinical Outcomes
5%
BIOSTAT-CHF
5%
High Risk
5%
Paradise
5%
